Novartis
NVS
#53
Rank
$166.98 B
Marketcap
$76.32
Share price
2.24%
Change (1 day)
-7.27%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Market capitalization of Novartis (NVS)

Market cap: $166.98 Billion

As of September 2022 Novartis has a market cap of $166.98 Billion. This makes Novartis the world's 53th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novartis from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$166.98 B-15.01%
2021$196.46 B-9.78%
2020$217.77 B1.37%
2019$214.83 B8.9%
2018$197.28 B0.05%
2017$197.18 B13.99%
2016$172.98 B-17.02%
2015$208.46 B-6.94%
2014$224.01 B15.09%
2013$194.64 B27.77%
2012$152.33 B10.31%
2011$138.09 B2.61%
2010$134.58 B7.64%
2009$125.03 B10.95%
2008$112.69 B-8.36%
2007$122.98 B-8.82%
2006$134.88 B10.03%
2005$122.58 B-0.05%
2004$122.65 B8.31%
2003$113.24 B24.58%
2002$90.90 B-2.26%
2001$93.00 B

End of Day market cap according to different sources

On Sep 28th, 2022 the market cap of Novartis was reported to be:

$166.98 Billion
by Yahoo Finance
$166.98 Billion
by CompaniesMarketCap
$166.56 Billion
by Nasdaq
$183.45 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$437.39 B 161.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$249.35 B 49.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$172.88 B 3.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$96.62 B-42.14%๐Ÿ‡ซ๐Ÿ‡ท France
$219.83 B 31.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$153.86 B-7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$180.30 B 7.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$59.52 B-64.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.06 B-94.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel